Jürgen Rehm

Author PubWeight™ 327.87‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 2013 16.76
2 The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med 2009 12.13
3 Alcohol and public health. Lancet 2005 10.82
4 Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015 7.99
5 Risky single-occasion drinking: bingeing is not bingeing. Addiction 2010 4.63
6 The cardioprotective association of average alcohol consumption and ischaemic heart disease: a systematic review and meta-analysis. Addiction 2012 3.74
7 Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. JAMA Psychiatry 2013 3.71
8 Developing the World Health Organization Disability Assessment Schedule 2.0. Bull World Health Organ 2010 3.31
9 The association of pattern of lifetime alcohol use and cause of death in the European prospective investigation into cancer and nutrition (EPIC) study. Int J Epidemiol 2013 3.23
10 Alcohol as a risk factor for type 2 diabetes: A systematic review and meta-analysis. Diabetes Care 2009 3.03
11 Irregular heavy drinking occasions and risk of ischemic heart disease: a systematic review and meta-analysis. Am J Epidemiol 2010 2.49
12 Are the 1976-1985 birth cohorts heavier drinkers? Age-period-cohort analyses of the National Alcohol Surveys 1979-2010. Addiction 2012 2.42
13 Alcohol consumption and the risk of morbidity and mortality for different stroke types--a systematic review and meta-analysis. BMC Public Health 2010 2.42
14 Reducing the global burden of hazardous alcohol use: a comparative cost-effectiveness analysis. J Stud Alcohol 2004 2.38
15 Alcohol as a correlate of unprotected sexual behavior among people living with HIV/AIDS: review and meta-analysis. AIDS Behav 2009 2.33
16 Alcohol consumption and risk of incident human immunodeficiency virus infection: a meta-analysis. Int J Public Health 2009 2.23
17 Causal considerations on alcohol and HIV/AIDS--a systematic review. Alcohol Alcohol 2010 2.22
18 Changes in illicit opioid use across Canada. CMAJ 2006 2.20
19 Illicit opioid use and its key characteristics: a select overview and evidence from a Canadian multisite cohort of illicit opioid users (OPICAN). Can J Psychiatry 2006 2.16
20 Carcinogenicity of acetaldehyde in alcoholic beverages: risk assessment outside ethanol metabolism. Addiction 2009 2.06
21 Age, period and cohort influences on beer, wine and spirits consumption trends in the US National Alcohol Surveys. Addiction 2004 2.01
22 The burden of cancer attributable to alcohol drinking. Int J Cancer 2006 2.01
23 Age-period-cohort modelling of alcohol volume and heavy drinking days in the US National Alcohol Surveys: divergence in younger and older adult trends. Addiction 2009 1.98
24 Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study. BMJ 2011 1.94
25 Alcohol consumption and non-communicable diseases: epidemiology and policy implications. Addiction 2011 1.93
26 Multicentre study of acute alcohol use and non-fatal injuries: data from the WHO collaborative study on alcohol and injuries. Bull World Health Organ 2006 1.90
27 Heroin-assisted treatment as a response to the public health problem of opiate dependence. Eur J Public Health 2002 1.89
28 Comparing alcohol consumption in central and eastern Europe to other European countries. Alcohol Alcohol 2007 1.89
29 How stable is the risk curve between alcohol and all-cause mortality and what factors influence the shape? A precision-weighted hierarchical meta-analysis. Eur J Epidemiol 2003 1.85
30 Lower Risk Cannabis use Guidelines for Canada (LRCUG): a narrative review of evidence and recommendations. Can J Public Health 2011 1.81
31 Effects of depression and social integration on the relationship between alcohol consumption and all-cause mortality. Addiction 2002 1.78
32 Harmful alcohol use. Alcohol Res Health 2003 1.74
33 Alcohol consumption, unprovoked seizures, and epilepsy: a systematic review and meta-analysis. Epilepsia 2010 1.73
34 Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study). J Urban Health 2005 1.73
35 Use of other opioids during methadone therapy: a population-based study. Addiction 2012 1.72
36 Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal community study in adolescents. Drug Alcohol Depend 2007 1.71
37 Differences and over-time changes in levels of prescription opioid analgesic dispensing from retail pharmacies in Canada, 2005-2010. Pharmacoepidemiol Drug Saf 2011 1.69
38 Antidepressant exposure during pregnancy and congenital malformations: is there an association? A systematic review and meta-analysis of the best evidence. J Clin Psychiatry 2013 1.65
39 The burden of death, disease, and disability due to alcohol in New Zealand. N Z Med J 2005 1.61
40 What can the Swiss and Dutch trials tell us about the potential risks associated with heroin prescribing? Drug Alcohol Rev 2003 1.57
41 Alcohol as a risk factor for pancreatitis. A systematic review and meta-analysis. JOP 2009 1.57
42 Hepatitis C virus transmission among oral crack users: viral detection on crack paraphernalia. Eur J Gastroenterol Hepatol 2008 1.56
43 Multi-level analysis of alcohol-related injury among emergency department patients: a cross-national study. Addiction 2005 1.53
44 Age-period-cohort influences on trends in past year marijuana use in the US from the 1984, 1990, 1995 and 2000 National Alcohol Surveys. Drug Alcohol Depend 2006 1.52
45 Using latent class analysis (LCA) to analyze patterns of drug use in a population of illegal opioid users. Drug Alcohol Depend 2006 1.51
46 International regulation of alcohol. BMJ 2008 1.48
47 Alcohol use disorders and mortality: a systematic review and meta-analysis. Addiction 2013 1.48
48 Alcohol-attributable cancer deaths and years of potential life lost in the United States. Am J Public Health 2013 1.46
49 Crack across Canada: Comparing crack users and crack non-users in a Canadian multi-city cohort of illicit opioid users. Addiction 2006 1.45
50 Determinants of overdose incidents among illicit opioid users in 5 Canadian cities. CMAJ 2004 1.44
51 Average volume of alcohol consumption and all-cause mortality in African Americans: the NHEFS cohort. Alcohol Clin Exp Res 2003 1.42
52 Understanding the parameters of non-medical use of prescription drugs: moving beyond mere numbers. Addiction 2007 1.42
53 Non-medical use of prescription opioids and public health in Canada: an urgent call for research and interventions development. Can J Public Health 2008 1.41
54 The effectiveness of psychosocial modalities in the treatment of alcohol problems in adults: a review of the evidence. Can J Psychiatry 2012 1.40
55 Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics. J Urban Health 2007 1.40
56 Does the association between alcohol consumption and depression depend on how they are measured? Alcohol Clin Exp Res 2007 1.38
57 Alcohol consumption as a risk factor for atrial fibrillation: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil 2010 1.38
58 Difficulties with telephone-based surveys on alcohol consumption in high-income countries: the Canadian example. Int J Methods Psychiatr Res 2012 1.34
59 Global alcohol exposure estimates by country, territory and region for 2005--a contribution to the Comparative Risk Assessment for the 2010 Global Burden of Disease Study. Addiction 2013 1.32
60 Surrogate alcohol: what do we know and where do we go? Alcohol Clin Exp Res 2007 1.30
61 Does price matter? The effect of decreased price on spirits consumption in Switzerland. Alcohol Clin Exp Res 2003 1.30
62 Gender differences in prevalence of substance use disorders among individuals with lifetime exposure to substances: results from a large representative sample. Am J Addict 2013 1.29
63 The impact of tobacco tax cuts on smoking initiation among Canadian young adults. Am J Prev Med 2006 1.28
64 Changes in and characteristics of admissions to treatment related to problematic prescription opioid use in Ontario, 2004-2009. Drug Alcohol Depend 2010 1.26
65 Clear criteria based on absolute risk: reforming the basis of guidelines on low-risk drinking. Drug Alcohol Rev 2011 1.26
66 Chronic diseases and conditions related to alcohol use. Alcohol Res 2013 1.24
67 Liver cirrhosis mortality in Europe, with special attention to Central and Eastern Europe. Eur Addict Res 2010 1.22
68 Alcohol consumption and mortality in Russia since 2000: are there any changes following the alcohol policy changes starting in 2006? Alcohol Alcohol 2013 1.22
69 How generalisable to community samples are clinical trial results for treatment of nicotine dependence: a comparison of common eligibility criteria with respondents of a large representative general population survey. Tob Control 2011 1.22
70 Comparative cost-effectiveness of policy instruments for reducing the global burden of alcohol, tobacco and illicit drug use. Drug Alcohol Rev 2006 1.21
71 Alcohol and infectious diseases: an overlooked causal linkage? Addiction 2009 1.21
72 What is best evidence in epidemiology? A reply to Stockwell (2012): the journal publishes both invited and unsolicited letters. Addiction 2013 1.20
73 Recall bias in case-crossover designs studying the potential influence of alcohol consumption. J Stud Alcohol Drugs 2010 1.19
74 Ischemic heart disease mortality and morbidity rates in former drinkers: a meta-analysis. Am J Epidemiol 2010 1.18
75 Prescription drug abuse in Canada and the diversion of prescription drugs into the illicit drug market. Can J Public Health 2005 1.18
76 Changes in alcohol consumption following a reduction in the price of spirits: a natural experiment in Switzerland. Addiction 2003 1.16
77 The relationship between self-reported drinking and BAC level in emergency room injury cases: is it a straight line? Alcohol Clin Exp Res 2010 1.16
78 The composition of alcohol products from markets in Lithuania and Hungary, and potential health consequences: a pilot study. Alcohol Alcohol 2008 1.16
79 Externalities from alcohol consumption in the 2005 US National Alcohol Survey: implications for policy. Int J Environ Res Public Health 2009 1.16
80 Mortality and potential years of life lost attributable to alcohol consumption in Canada in 2005. BMC Public Health 2012 1.15
81 Social cost of heavy drinking and alcohol dependence in high-income countries. Int J Public Health 2009 1.14
82 Gender differences in health-related quality of life among cannabis users: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend 2011 1.12
83 Global alcohol-attributable deaths from cancer, liver cirrhosis, and injury in 2010. Alcohol Res 2013 1.12
84 What do we know about the economic impact of fetal alcohol spectrum disorder? A systematic literature review. Alcohol Alcohol 2011 1.10
85 Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada. J Urban Health 2004 1.10
86 Determining the best population-level alcohol consumption model and its impact on estimates of alcohol-attributable harms. Popul Health Metr 2012 1.10
87 The quality of alcohol products in Vietnam and its implications for public health. Int J Environ Res Public Health 2009 1.09
88 Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: a naturalistic study in 2694 patients. Drug Alcohol Depend 2008 1.08
89 Disability associated with alcohol abuse and dependence. Alcohol Clin Exp Res 2010 1.08
90 Racial and ethnic differences in all-cause mortality risk according to alcohol consumption patterns in the national alcohol surveys. Am J Epidemiol 2011 1.08
91 The effect of alcohol consumption on emergency department services use among injured patients: A cross-national emergency room study. J Stud Alcohol 2006 1.07
92 Feasibility and outcome of HCV treatment in a Canadian federal prison population. Am J Public Health 2005 1.07
93 Mortality and potential years of life lost attributable to alcohol consumption by race and sex in the United States in 2005. PLoS One 2013 1.07
94 The relationship between alcohol consumption and fatal motor vehicle injury: high risk at low alcohol levels. Alcohol Clin Exp Res 2012 1.06
95 Unrecorded alcohol: a threat to public health? Addiction 2009 1.06
96 Risk and speed of transitions to first alcohol dependence symptoms in adolescents: a 10-year longitudinal community study in Germany. Addiction 2008 1.06
97 Reduction of alcohol consumption and subsequent mortality in alcohol use disorders: systematic review and meta-analyses. J Clin Psychiatry 2013 1.05
98 Health care burden and cost associated with fetal alcohol syndrome: based on official Canadian data. PLoS One 2012 1.05
99 Prevalence of fetal alcohol spectrum disorders in child care settings: a meta-analysis. Pediatrics 2013 1.05
100 Comparing heroin users and prescription opioid users in a Canadian multi-site population of illicit opioid users. Drug Alcohol Rev 2008 1.05
101 Alcohol and cannabis use as risk factors for injury--a case-crossover analysis in a Swiss hospital emergency department. BMC Public Health 2009 1.04
102 Drinking and its burden in a global perspective: policy considerations and options. Eur Addict Res 2003 1.04
103 Doing it by numbers: a simple approach to reducing the harms of alcohol. J Psychopharmacol 2014 1.04
104 Cocaine use in Europe - a multi-centre study: patterns of use in different groups. Eur Addict Res 2004 1.03
105 Heavy drinking occasions in relation to ischaemic heart disease mortality-- an 11-22 year follow-up of the 1984 and 1995 US National Alcohol Surveys. Int J Epidemiol 2011 1.02
106 Assessing the prevalence of nonmedical prescription opioid use in the general Canadian population: methodological issues and questions. Can J Psychiatry 2010 1.02
107 Risk of injury due to alcohol: evaluating potential bias using the case-crossover usual-frequency method. Epidemiology 2013 1.01
108 Determination of lifetime injury mortality risk in Canada in 2002 by drinking amount per occasion and number of occasions. Am J Epidemiol 2008 1.01
109 Use and nonmedical use of prescription opioid analgesics in the general population of Canada and correlations with dispensing levels in 2009. Pain Res Manag 2013 1.00
110 Alcohol-attributable burden of disease and injury in Canada, 2004. Int J Public Health 2011 1.00
111 How many people in Canada use prescription opioids non-medically in general and street drug using populations? Can J Public Health 2009 0.99
112 Unrecorded alcohol consumption in Russia: toxic denaturants and disinfectants pose additional risks. Interdiscip Toxicol 2011 0.98
113 Alcohol-caused mortality in australia and Canada: scenario analyses using different assumptions about cardiac benefit. J Stud Alcohol Drugs 2007 0.98
114 High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005-2009. Pharmacoepidemiol Drug Saf 2013 0.98
115 Evaluating long-term effects of heroin-assisted treatment: the results of a 6-year follow-up. Eur Addict Res 2003 0.98
116 Association between quality of cheap and unrecorded alcohol products and public health consequences in Poland. Alcohol Clin Exp Res 2009 0.98
117 Smoking-attributable mortality and expected years of life lost in Canada 2002: conclusions for prevention and policy. Chronic Dis Can 2007 0.97
118 Is contaminated unrecorded alcohol a health problem in the European Union? A review of existing and methodological outline for future studies. Addiction 2011 0.97
119 Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses. Subst Use Misuse 2006 0.97
120 Problems with the graduated frequency approach to measuring alcohol consumption: results from a pilot study in Toronto, Canada. Alcohol Alcohol 2004 0.97
121 Alcohol under the radar: do we have policy options regarding unrecorded alcohol? Int J Drug Policy 2011 0.97
122 Disentangling gender and age effects on risky single occasion drinking during adolescence. Eur J Public Health 2006 0.96
123 Comparative risk assessment of carcinogens in alcoholic beverages using the margin of exposure approach. Int J Cancer 2012 0.96
124 Decreased taxation, spirits consumption and alcohol-related problems in Switzerland. J Stud Alcohol 2004 0.96
125 Cost of fetal alcohol spectrum disorder diagnosis in Canada. PLoS One 2013 0.95
126 A comparison of the prevalence of prenatal alcohol exposure obtained via maternal self-reports versus meconium testing: a systematic literature review and meta-analysis. BMC Pregnancy Childbirth 2014 0.95
127 Alcohol taxation policy in Thailand: implications for other low- to middle-income countries. Addiction 2012 0.95
128 The prevalence of mental health and pain symptoms in general population samples reporting nonmedical use of prescription opioids: a systematic review and meta-analysis. J Pain 2012 0.95
129 Cannabis use in Canada: the need for a 'public health' approach. Can J Public Health 2009 0.95
130 Harms of prescription opioid use in the United States. Subst Abuse Treat Prev Policy 2014 0.94
131 Anxiety and mood disorders and cannabis use. Am J Drug Alcohol Abuse 2010 0.94
132 Epidemiology-based risk assessment using the benchmark dose/margin of exposure approach: the example of ethanol and liver cirrhosis. Int J Epidemiol 2010 0.93
133 When risk factors combine: the interaction between alcohol and smoking for aerodigestive cancer, coronary heart disease, and traffic and fire injury. Addict Behav 2006 0.93
134 Global burden of injuries attributable to alcohol consumption in 2004: a novel way of calculating the burden of injuries attributable to alcohol consumption. Popul Health Metr 2012 0.93
135 Correlations between prescription opioid analgesic dispensing levels and related mortality and morbidity in Ontario, Canada, 2005-2011. Drug Alcohol Rev 2013 0.93
136 Non-medical use of prescription opioids and prescription opioid-related harms: why so markedly higher in North America compared to the rest of the world? Addiction 2013 0.93
137 Alcohol intake revisited: risks and benefits. Curr Atheroscler Rep 2012 0.93
138 A typology of cannabis-related problems among individuals with repeated illegal drug use in the first three decades of life: Evidence for heterogeneity and different treatment needs. Drug Alcohol Depend 2009 0.93
139 The burden of mental illness and addiction in ontario. Can J Psychiatry 2013 0.92
140 Undergraduate drinking and academic performance: a prospective investigation with objective measures. J Stud Alcohol Drugs 2009 0.92
141 Nonmedical prescription opioid use and mental health and pain comorbidities: a narrative review. Can J Psychiatry 2011 0.92
142 Trends and changes in prescription opioid analgesic dispensing in Canada 2005-2012: an update with a focus on recent interventions. BMC Health Serv Res 2014 0.92
143 Alcohol-attributable morbidity and resulting health care costs in Canada in 2002: recommendations for policy and prevention. J Stud Alcohol Drugs 2007 0.91
144 Estimating uncertainty of alcohol-attributable fractions for infectious and chronic diseases. BMC Med Res Methodol 2011 0.91
145 Ethyl carbamate in alcoholic beverages from Mexico (tequila, mezcal, bacanora, sotol) and Guatemala (cuxa): market survey and risk assessment. Int J Environ Res Public Health 2009 0.91
146 Bipolar disorder and co-occurring cannabis use disorders: characteristics, co-morbidities and clinical correlates. Psychiatry Res 2013 0.91
147 Eyes wide shut?--A conceptual and empirical critique of methadone maintenance treatment. Eur Addict Res 2005 0.91
148 Alcohol in Mayan Guatemala: consumption, distribution, production and composition of cuxa. Addiction 2009 0.91
149 Assessing the prevalence of non-medical prescription opioid use in the Canadian general adult population: evidence of large variation depending on survey questions used. BMC Psychiatry 2013 0.90
150 Comorbid depression among untreated illicit opiate users: results from a multisite Canadian study. Can J Psychiatry 2005 0.89
151 Risk perception, somatization, and self report of complaints related to electromagnetic fields--a randomized survey study. Int J Hyg Environ Health 2002 0.89
152 Feasibility and impact of brief interventions for frequent cannabis users in Canada. J Subst Abuse Treat 2012 0.89
153 Prevalence and key covariates of non-medical prescription opioid use among the general secondary student and adult populations in Ontario, Canada. Drug Alcohol Rev 2013 0.89
154 Quality of illegally and informally produced alcohol in Europe: Results from the AMPHORA project. Adicciones 2011 0.89
155 Fetal alcohol spectrum disorder prevalence estimates in correctional systems: a systematic literature review. Can J Public Health 2011 0.89
156 Is alcopop consumption in Switzerland associated with riskier drinking patterns and more alcohol-related problems? Addiction 2006 0.87
157 Non-medical use of prescription opioids among Ontario adults: data from the 2008/2009 CAMH Monitor. Can J Public Health 2011 0.87
158 Recent Developments in Prescription Opioid-related Dispensing and Harm Indicators in Ontario, Canada. Pain Physician 2015 0.87
159 Predictors of methadone maintenance treatment utilization in a multisite cohort of illicit opioid users (OPICAN). J Subst Abuse Treat 2007 0.87
160 Exploring the association between lifetime prevalence of mental illness and transition from substance use to substance use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions (NESARC). Am J Addict 2013 0.87
161 Smoking cessation and lung cancer mortality in a cohort of middle-aged Canadian women. Ann Epidemiol 2005 0.87
162 Non-medical prescription opioid use, prescription opioid-related harms and public health in Canada: an update 5 years later. Can J Public Health 2014 0.87
163 The world health organization's global monitoring system on alcohol and health. Alcohol Res 2013 0.87
164 Substance Use and Related Harms Among Adolescents With and Without Traumatic Brain Injury. J Head Trauma Rehabil 2015 0.87
165 Cannabis and traffic collision risk: findings from a case-crossover study of injured drivers presenting to emergency departments. Int J Public Health 2013 0.86
166 Chemical analysis and risk assessment of diethyl phthalate in alcoholic beverages with special regard to unrecorded alcohol. PLoS One 2009 0.86
167 Smoking-attributable morbidity: acute care hospital diagnoses and days of treatment in Canada, 2002. BMC Public Health 2007 0.86
168 Public opinion towards supervised injection facilities and heroin-assisted treatment in Ontario, Canada. Int J Drug Policy 2007 0.86
169 Typologies of cannabis users and associated characteristics relevant for public health: a latent class analysis of data from a nationally representative Canadian adult survey. Int J Methods Psychiatr Res 2010 0.86
170 Deaths related to the use of prescription opioids. CMAJ 2009 0.86
171 Alcohol and ischaemic heart disease risk--finally moving beyond interpretation of observational epidemiology. Addiction 2015 0.86
172 Alcohol, the heart and the cardiovascular system: what do we know and where should we go? Drug Alcohol Rev 2011 0.86
173 Criminal behavior in opioid-dependent patients before and during maintenance therapy: 6-year follow-up of a nationally representative cohort sample. J Forensic Sci 2012 0.86
174 Associations of hair cortisol concentration with self-reported measures of stress and mental health-related factors in a pooled database of diverse community samples. Stress 2014 0.85
175 Illegal drug-attributable morbidity in Canada 2002. Drug Alcohol Rev 2007 0.85
176 Cannabis use and cannabis use disorders among individuals with mental illness. Compr Psychiatry 2013 0.85
177 The composition of unrecorded alcohol from eastern Ukraine: is there a toxicological concern beyond ethanol alone? Food Chem Toxicol 2010 0.85
178 Cost of specialized addiction treatment of clients with fetal alcohol spectrum disorder in Canada. BMC Public Health 2013 0.84
179 A novel nonparametric approach for estimating cut-offs in continuous risk indicators with application to diabetes epidemiology. BMC Med Res Methodol 2009 0.84
180 A prospective cohort study on orally administered heroin substitution for severely addicted opioid users. Addiction 2006 0.84
181 Estimating regression to the mean and true effects of an intervention in a four-wave panel study. Addiction 2007 0.84
182 [Co-morbidity: psychiatric disorder of opiate addicts at entry into heroin-assisted treatment]. Psychiatr Prax 2002 0.84
183 Safer injection facilities (SIFs) for injection drug users (IDUs) in Canada. A review and call for an evidence-focused pilot trial. Can J Public Health 2002 0.83
184 Prevalence and associated factors of hepatitis C infection (HCV) in a multi-site Canadian population of illicit opioid and other drug users (OPICAN). Can J Public Health 2007 0.83
185 Gender differences in socioeconomic inequality of alcohol-attributable mortality: A systematic review and meta-analysis. Drug Alcohol Rev 2014 0.83
186 Drug-related overdose deaths in British Columbia and Ontario, 1992-2004. Can J Public Health 2006 0.83
187 Personality as a predictor of unprotected sexual behavior among people living with HIV/AIDS: a systematic review. AIDS Behav 2014 0.82
188 Complaints of heroin-maintained patients: A survey of symptoms ascribed to diacetylmorphine. Drug Alcohol Depend 2005 0.82
189 Artisanal alcohol production in Mayan Guatemala: chemical safety evaluation with special regard to acetaldehyde contamination. Sci Total Environ 2009 0.82
190 Avoidable portion of tobacco-attributable acute care hospital days and its cost due to implementation of different intervention strategies in Canada. Int J Environ Res Public Health 2009 0.81
191 Can resveratrol in wine protect against the carcinogenicity of ethanol? A probabilistic dose-response assessment. Int J Cancer 2013 0.81
192 Dosage regimes in the prescription of heroin and other narcotics to chronic opioid addicts in Switzerland--Swiss national cohort study. Eur Addict Res 2004 0.81
193 Health and social services accessed by a cohort of Canadian illicit opioid users outside of treatment. Can J Public Health 2006 0.81
194 Prevalence of pain among nonmedical prescription opioid users in substance use treatment populations: systematic review and meta-analyses. Pain Physician 2013 0.81
195 Developing a method to derive alcohol-attributable fractions for HIV/AIDS mortality based on alcohol's impact on adherence to antiretroviral medication. Popul Health Metr 2011 0.81
196 Social relationships as a major determinant in the valuation of health states. Qual Life Res 2011 0.81
197 Reductions in non-medical prescription opioid use among adults in Ontario, Canada: are recent policy interventions working? Subst Abuse Treat Prev Policy 2013 0.81
198 Prevalence of hepatitis and HIV infections and vaccination rates in patients entering the heroin-assisted treatment in Switzerland between 1994 and 2002. Eur J Epidemiol 2006 0.81
199 A predictive microsimulation model to estimate the clinical relevance of reducing alcohol consumption in alcohol dependence. Eur Addict Res 2014 0.81
200 Cannabis use and mental health-related quality of life among individuals with anxiety disorders. J Anxiety Disord 2012 0.80
201 Causality between polyhexamethyleneguanidine occurrence in unrecorded alcohol and cholestatic hepatitis outbreak in Russia. Clin Toxicol (Phila) 2012 0.80
202 Taxometric analysis of DSM-IV and DSM-5 alcohol use disorders. Drug Alcohol Depend 2012 0.80
203 Cancer risk assessment of ethyl carbamate in alcoholic beverages from Brazil with special consideration to the spirits cachaça and tiquira. BMC Cancer 2010 0.80
204 Exploring daily variations of drinking in the Swiss general population. A growth curve analysis. Int J Methods Psychiatr Res 2008 0.80
205 Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations. Am J Public Health 2017 0.79
206 [The prevalence of psychiatric co-morbidity among opioid addicts]. Psychiatr Prax 2002 0.79
207 Efficacy of an alcohol-focused intervention for improving adherence to antiretroviral therapy (ART) and HIV treatment outcomes - a randomised controlled trial protocol. BMC Infect Dis 2014 0.79
208 What research is being done on prenatal alcohol exposure and fetal alcohol spectrum disorders in the Russian research community? Alcohol Alcohol 2013 0.79
209 A literature review of cost-benefit analyses for the treatment of alcohol dependence. Int J Environ Res Public Health 2011 0.79
210 The effects of capping the alcohol consumption distribution and relative risk functions on the estimated number of deaths attributable to alcohol consumption in the European Union in 2004. BMC Med Res Methodol 2013 0.79
211 Cost of speech-language interventions for children and youth with foetal alcohol spectrum disorder in Canada. Int J Speech Lang Pathol 2013 0.79
212 Difficulty in demonstrating a risk from drinking pattern in fourteen years of coronary heart disease morbidity and mortality: the Lung Health Study. Addict Behav 2005 0.79
213 Modes and impact of coercive inpatient treatment for drug-related conditions in Switzerland. Eur Addict Res 2002 0.79
214 Six-year mortality rates of patients in methadone and buprenorphine maintenance therapy: results from a nationally representative cohort study. J Clin Psychopharmacol 2011 0.79
215 Predicting the outcome of eating disorders using structural equation modeling. Int J Eat Disord 2003 0.79
216 What happens if people start drinking mouthwash as surrogate alcohol? A quantitative risk assessment. Food Chem Toxicol 2012 0.79
217 The potential impact of increased treatment rates for alcohol dependence in the United Kingdom in 2004. BMC Health Serv Res 2014 0.78
218 12-month follow-up of an exploratory 'brief intervention' for high-frequency cannabis users among Canadian university students. Subst Abuse Treat Prev Policy 2012 0.78
219 Measuring the burden: alcohol's evolving impact on individuals, families, and society. Alcohol Res 2013 0.78
220 Alcohol and non-communicable diseases (NCDs): time for a serious international public health effort. Addiction 2011 0.78
221 The impact of probable anxiety and mood disorder on self-reported collisions: a population study. J Affect Disord 2012 0.78
222 Measuring the burden: alcohol's evolving impact. Alcohol Res 2013 0.78
223 Alcohol consumption, stroke and public health--an overlooked relation? Addiction 2006 0.78
224 Screening for antisocial personality disorder in drug users--a qualitative exploratory study on feasibility. Int J Methods Psychiatr Res 2003 0.78
225 Cost of privatisation versus government alcohol retailing systems: Canadian example. Drug Alcohol Rev 2012 0.78
226 Alcohol and non-communicable diseases-cancer, heart disease and more. Addiction 2011 0.77
227 Average volume of alcohol consumption, patterns of drinking and mortality among young Europeans in 1999. Addiction 2002 0.77
228 Hepatitis C, illicit drug use and public health: does Canada really have a viable plan? Can J Public Health 2007 0.77
229 Strategies for evaluating the economic value of drugs in alcohol dependence treatment. Drug Alcohol Depend 2011 0.77
230 Why does society accept a higher risk for alcohol than for other voluntary or involuntary risks? BMC Med 2014 0.77
231 The international study on alcohol and infectious diseases: three priorities for research. Addiction 2012 0.76
232 Two-chosen-one taxation: examining its potential effectiveness to reduce drinking initiation and heavy alcohol consumption in low- to middle-income countries. Addiction 2012 0.76
233 Comparison perception of singular transcranial magnetic stimuli by subjectively electrosensitive subjects and general population controls. Bioelectromagnetics 2005 0.76
234 Sativex Associated With Behavioral-Relapse Prevention Strategy as Treatment for Cannabis Dependence: A Case Series. J Addict Med 2016 0.76
235 Commentary on Jarl & Gerdtham (2012): further evidence of the reversal of alcohol-related risk of oesophageal cancer after alcohol cessation. Addiction 2012 0.75
236 What is the main source of human exposure to higher alcohols and is there a link to immunotoxicity? Immunopharmacol Immunotoxicol 2013 0.75
237 An exploratory approach to analyzing alcohol control policy opinions held by Ontario adults. Int J Environ Res Public Health 2010 0.75
238 The disease burden of alcohol consumption. CMAJ 2007 0.75
239 Considering prescription opioid-related harms in the population: response to commentaries. Addiction 2014 0.75
240 Perhaps not such a great threat to public health in the UK. BMJ 2012 0.75
241 Alcohol-related road traffic injury and Global Burden of Disease 2010 - Authors' reply. Lancet 2013 0.75
242 On French and American paradoxes. Addiction 2013 0.75
243 Phenibut dependence. BMJ Case Rep 2013 0.75
244 On the evidence of a cardioprotective effect of alcohol consumption. Addiction 2013 0.75
245 Commentary on Hickman et al. (2009): The place of risk in drug policies. Addiction 2009 0.75
246 Lack of evidence for a causal association between the type of alcoholic beverage and the incidence of acute pancreatitis. Pancreas 2011 0.75
247 J-shape or linear relationship between alcohol consumption and depression: does it matter? Addiction 2005 0.75
248 Is it possible to distinguish vodka by taste? Comment on Structurability: a collective measure of the structural differences in vodkas. J Agric Food Chem 2010 0.75
249 Letter to the editor in regard to Gil, Polikina, Koroleva, McKee, Tomkins, and Leon (2009): "Availability and characteristics of nonbeverage alcohols in 17 Russian cities in 2007". Unrecorded alcohol in Russia: is there more to it than just ethanol? Alcohol Clin Exp Res 2009 0.75
250 Moderate red wine drinking does not help cut women's breast cancer risk. J Womens Health (Larchmt) 2012 0.75
251 Letter to the editor in regard to Baek, Lee, and Kwon (2010): "Influence of dissolved oxygen concentration on the pharmacokinetics of alcohol in humans": does oxygenated alcohol reduce hangover? Alcohol Clin Exp Res 2010 0.75
252 Alcohol consumption, alcohol dependence, and related mortality in Italy in 2004: effects of treatment-based interventions on alcohol dependence. Subst Abuse Treat Prev Policy 2013 0.75
253 The effect of phytophenols in alcoholic beverages on alcohol dehydrogenase 1: is there really evidence for an inhibition of metabolic toxicity of alcohol? Metabolism 2009 0.75
254 Selection and self-selection: how to determine the real impact of alcohol on health-care utilization and costs? Addiction 2005 0.75
255 Naltrexone may block euphoria-like placebo effect. BMJ Case Rep 2013 0.75
256 Assessing quitter effects: disaggregating current nondrinkers. J Am Geriatr Soc 2009 0.75
257 Conflict and diarrheal and related diseases: a global analysis. J Epidemiol Glob Health 2013 0.75
258 [Quitting hash. The readiness for behaviour change among cannabis users in Switzerland]. Int J Public Health 2007 0.75
259 [Volume and profile of alcohol consumption among students and classmates as predictors of aggression and victimization: a multilevel analysis among Swiss adolescents]. Soz Praventivmed 2006 0.75
260 [Prognostic factors from a long-term follow-up of heroin-assisted treatment in Switzerland 1994-2007]. Psychiatr Prax 2010 0.75
261 The Action Plan--a new instrument to collect data on interventions in secondary prevention in adolescents. Subst Use Misuse 2005 0.75
262 Acute Alcohol Consumption Directly Increases HIV Transmission Risk: A Randomized Controlled Experiment. J Acquir Immune Defic Syndr 2017 0.75
263 Comparing Medical and Recreational Cannabis Users on Socio-Demographic, Substance and Medication Use, and Health and Disability Characteristics. Eur Addict Res 2017 0.75
264 Vaporizing cannabis through e-cigarettes: Prevalence and socio-demographic correlates among Ontario high school students. Can J Public Health 2016 0.75
265 Evidence from regression-discontinuity analyses for beneficial effects of a criterion-based increase in alcohol treatment. Int J Methods Psychiatr Res 2012 0.75
266 Temporal Changes in Alcohol-Related Morbidity and Mortality in Germany. Eur Addict Res 2015 0.75
267 Avoidable alcohol-attributable criminality and its costs due to selected interventions in Canada. Int J Drug Policy 2011 0.75
268 Six-Year Outcome of Opioid Maintenance Treatment in Heroin-Dependent Patients: Results from a Naturalistic Study in a Nationally Representative Sample. Eur Addict Res 2017 0.75
269 Compulsory treatment - what do we know and where should we go? Eur Addict Res 2002 0.75
270 Roadway Aggression Among Drivers and Passengers With or Without a History of Traumatic Brain Injury. Violence Vict 2017 0.75
271 Alcohol in Primary Care. Differential characteristics between alcohol-dependent patients who are receiving or not receiving treatment. Adicciones 2016 0.75
272 Development of a monitoring system for heroin-assisted substitution treatment in Switzerland. Soz Praventivmed 2002 0.75
273 Is there a relationship between alcohol quality and health? Alcohol Alcohol 2012 0.75
274 Alcohol Consumption and Inpatient Health Service Utilization in a Cohort of Patients With Alcohol Dependence After 20 Years of Follow-up. Alcohol Alcohol 2017 0.75
275 Long-term follow-up of orally administered diacetylmorphine substitution treatment. Eur Addict Res 2010 0.75
276 Alcoholic beverage strength discrimination by taste may have an upper threshold. Alcohol Clin Exp Res 2014 0.75
277 Corrigendum: Barriers to Alcohol Screening Among Hypertensive Patients and the Role of Stigma: Lessons for the Implementation of Screening and Brief Interventions in European Primary Care Settings. Alcohol Alcohol 2017 0.75
278 Individuals receiving specialized treatment for drug and alcohol dependence and gambling disorder in Israel--characteristics and implications for prevalence estimates. Subst Abus 2014 0.75